The International Network of People Who Use Drugs and Drugreporter are glad to announce the winners of the #Morethan video contest!
Vitaly Milonov, a Russian government politician notorious for anti-gay and antisemitic remarks, has found a new enemy: The Andrey Rylkov Foundation, a harm reduction organisation in Moscow.
More than 400 professionals and community activists gathered in Prague to attend the 5th European Harm Reduction Conference. Watch and share Drugreporter’s video report!
Application is now open for the online training course on working with the media, by the Rights Reporter Foundation (Drugreporter).
Cannabis legalization is coming to Europe: the governments of Luxembourg and Switzerland announced their plan to regulate the production and sale of cannabis products, other countries may follow their lead soon. What do drug policy professionals and activists think about this? We asked a couple of experts to comment, pro and con. We publish their views without editing.
Robert Veverka, an activist, a politician and the editor of the most popular Czech cannabis magazine, Legalizace, is being prosecuted for “inciting and promoting toxicomania.” Read our interview with him.
The Harm The Key Principles of Harm Reduction are an innovative set of tools developed through the HR4Homelessness Project. The innovation lies in their capacity to translate existing experiences and knowledge on Harm Reduction into actionable guidance through an open, iterative and evolving framework.
The mass detention and forced treatment of people who use drugs in Afghanistan reminds us of the darkest periods of history.
An organisation of progressive young people, The Dignity Movement, is fighting for a more inclusive and supportive drug policy in Armenia. We interviewed the president of the organisation, Ashot Gevorgyan.
On July 6th 2021, our close friend, colleague, and world-renowned addictologist Tomáš Zábranský left us. This text, written by his friend and well-known cannabis activist Jindřich Bayer, is dedicated to him. It asks the question, how did it all start? What was the context for Tomas’ decision to contribute to reforming drug policy on a global level?